Association between immune‐related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
Fundamental & Clinical Pharmacology . 38 ( 2 ) : 369-379
DOI: 10.1111/fcp.12966
Journal article
see the publication